GlassScriptPhysician profile
Ali Mortazavi
NPI 1609863802
$114,679.15
in general payments reported to CMS, 2019-2025
15 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $28K · 2021: $30K · 2022: $9,591 · 2023: $1,101 · 2024: $1,811 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,342.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $110,817.14 | 2019-2025 | Fortress, Sable, Citadel |
| Spineology INC. | $1,821.92 | 2022 | |
| Xtant Medical INC | $562.00 | 2021-2022 | |
| Boston Scientific Corporation | $387.42 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Becton, Dickinson and Company | $179.68 | 2025 | Hemosphere |
| Bioventus LLC | $150.03 | 2021 | |
| Intrinsic Therapeutics | $149.72 | 2024 | Barricaid Acd (Annular Closure Device) |
| Seaspine Orthopedics Corporation | $122.38 | 2021 | |
| Nevro Corp. | $120.89 | 2023 | Senza |
| Spine Wave, INC. | $119.36 | 2019 | |
| Painteq LLC | $105.55 | 2023 | Painteq |
| Vertiflex, INC. | $72.18 | 2019 | |
| Fidia Pharma USA INC. | $51.23 | 2022 | |
| Horizon Therapeutics Plc | $19.65 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$869,212.47 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Mortazavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.